News Line

Archive for September 2nd, 2010

Genzyme reaches out to Sanofi to raise its bid if

September 2, 2010

Genzyme is good to sell, "but not $ 69 per share, or $ 18.5 billion in total, as proposed by Sanofi-Aventis. In recent hours, Henri Termeer, CEO of U.S. biotech coveted by the French laboratory, has changed its tone. After contrast, twice a categorical end of inadmissibility on the ...